Our findings indicate that ISM1 deficiency exacerbates airway inflammation and airway hyperresponsiveness (AHR), whereas intratracheal (i.t.)delivery of recombinant ISM1 (rISM1) attenuates HDM-induced airway inflammation. Here, ISM1 is linked to airway hyperresponsiveness.